The future of cystic fibrosis care: a global perspective

SC Bell, MA Mall, H Gutierrez, M Macek… - The Lancet …, 2020 - thelancet.com
Executive summary The past six decades have seen remarkable improvements in health
outcomes for people with cystic fibrosis, which was once a fatal disease of infants and young …

Return on investment of public health interventions: a systematic review

R Masters, E Anwar, B Collins, R Cookson… - J Epidemiol …, 2017 - jech.bmj.com
Background Public sector austerity measures in many high-income countries mean that
public health budgets are reducing year on year. To help inform the potential impact of these …

Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health …

A Pichon-Riviere, M Drummond, A Palacios… - The Lancet Global …, 2023 - thelancet.com
Background Assessment of the efficiency of interventions is paramount to achieving
equitable health-care systems. One key barrier to the widespread use of economic …

[HTML][HTML] Cost–effectiveness thresholds: pros and cons

MY Bertram, JA Lauer, K De Joncheere… - Bulletin of the World …, 2016 - ncbi.nlm.nih.gov
Cost–effectiveness analysis is used to compare the costs and outcomes of alternative policy
options. Each resulting cost–effectiveness ratio represents the magnitude of additional …

A health opportunity cost threshold for cost-effectiveness analysis in the United States

DJ Vanness, J Lomas, H Ahn - Annals of internal medicine, 2021 - acpjournals.org
Background: Cost-effectiveness analysis is an important tool for informing treatment
coverage and pricing decisions, yet no consensus exists about what threshold for the …

[HTML][HTML] Country-level cost-effectiveness thresholds: initial estimates and the need for further research

B Woods, P Revill, M Sculpher, K Claxton - Value in Health, 2016 - Elsevier
Background Cost-effectiveness analysis can guide policymakers in resource allocation
decisions. It assesses whether the health gains offered by an intervention are large enough …

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

A Angelis, A Lange, P Kanavos - The European Journal of Health …, 2018 - Springer
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …

Perspective and costing in cost-effectiveness analysis, 1974–2018

DD Kim, MC Silver, N Kunst, JT Cohen… - …, 2020 - Springer
Objective Our objective was to examine perspective and costing approaches used in cost-
effectiveness analyses (CEAs) and the distribution of reported incremental cost …

Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data

J Ochalek, J Lomas, K Claxton - BMJ global health, 2018 - gh.bmj.com
The economic evaluation of healthcare interventions requires an assessment of whether the
improvement in health outcomes they offer exceeds the improvement in health that would …

Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial

A Rangan, SD Brealey, A Keding, B Corbacho… - The Lancet, 2020 - thelancet.com
Background Manipulation under anaesthesia and arthroscopic capsular release are costly
and invasive treatments for frozen shoulder, but their effectiveness remains uncertain. We …